Former FDA Official Howard Sklamberg Quoted in The Hill on Impact of HHS Layoffs
April 8, 2025
Life Sciences & Healthcare Regulatory partner and former FDA Deputy Commissioner for Global Regulatory Operations and Policy Howard Sklamberg was quoted in The Hill’s article, “4 key takeaways as Trump’s sweeping HHS layoffs begin.” The piece explores the wide-reaching effects of mass layoffs across HHS, including a major restructuring of the FDA.
Sklamberg pointed out that many people who received layoffs were from policy offices, which guided companies that would invest in developing drugs and medical devices. Sklamberg noted that the changes could “fundamentally change FDA and bring it back to what it was decades ago,” and “put FDA below European regulatory agencies” regarding their expertise and ability to oversee drug development.
